Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells

Molecular Biology of the Cell

Volumn 11, Issue 6, 2000, Pages 2069-2083

  Qiu, Ling ^a   Burgess, Andrew ^a   Fairlie, David P ^a   Leonard, Helen ^a   Parsons, Peter G ^a   Gabrielli, Brian G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZELAIC ACID; ENZYME INHIBITOR; HISTONE; HISTONE DEACETYLASE; TOXIN;

ACETYLATION; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MITOSIS; PRIORITY JOURNAL; TUMOR CELL;

EID: 0034086168     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.11.6.2069     Document Type: Article

References (39)

1. Archer, S.Y., Meng, S., Shei, A., and Hodin, R.A. (1998). p21 (WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. USA 95, 6791-6796.
2. Breslow, R., Jursic, B., Yan, Z.F., Friedman, E., Leng, L., Ngo, L., Rifkind, R.A., and Marks, P.A. (1991). Potent cytodifferentiating agents related to hexamethylenebisacetamide. Proc. Natl. Acad. Sci. USA 88, 5542-5546.
3. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, MA., Lassota, P., and Traganos, F. (1992). Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808.
4. Downes, C.S., Clarke, D.J., Mullinger, A.M., Gimenez-Abian, J.F., Creighton, A.M., and Johnson, R.T. (1994). A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372, 467-470.
5. Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledge, S.J., and Reed, S.I. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013-1023.
6. Dulic, V., Lees, E., and Reed, S.I. (1992). Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257, 1958-1961.
7. Ekwall, K., Olsson, T., Turner, B.M., Cranston, G., and Allshire, R.C. (1997). Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell 91, 1021-1032.
8. Elledge, S.J. (1996). Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664-1672.
9. Gabrielli, B.G., Clark, J.M., McCormack, A.K., and Ellem, K.A. (1997). Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis. Oncogene 15, 749-758.
10. Gabrielli, B.G., De Souza, C.P., Tonks, I.D., Clark, J.M., Hayward, N.K., and Ellem, K.A. (1996). Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J. Cell Sci. 109, 1081-1093.
11. Grunstein, M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-352.
12. Harrwell, L.H., and Kastan, M.B. (1994). Cell cycle control and cancer. Science 266, 1821-1828.
13. Jin, P., Gu, Y., and Morgan, D.O. (1996). Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J. Cell Biol. 134, 963-970.
14. Kiyokawa, H., Richon, V.M., Rifkind, R.A., and Marks, P.A. (1994). Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol. Cell. Biol. 14, 7195-7203.
15. Lallemand, F., Courilleau, D., Buquet-Fagot, C., Atfi, A., Montagne, M.N., and Mester, J. (1999). Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication. Exp. Cell Res. 247, 432-440.
16. Lavin, M.F., and Shiloh, Y. (1996). Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction. Curr. Opin. Immunol. 8, 459-464.
17. Lengauer, C, Kinzler, K.W., and Vogelstein, B. (1997). Genetic instability in colorectal cancers. Nature 386, 623-627.
18. Lock, R.B. (1992). Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Cancer Res. 52, 1817-1822.
19. Lock, R.B., Galperina, O.V., Feldhoff, R.C., and Rhodes, L.J. (1994). Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res. 54, 4933-4939.
20. Megee, P.C., Morgan, B.A., and Smith, M.M. (1995). Histone H4 and the maintenance of genome integrity. Genes Dev. 9, 1716-1727.
21. Morgan, D.O. (1995). Principles of CDK regulation. Nature 374, 131-134.
22. Pagano, M., Pepperkok, R., Lukas, J., Baldin, V., Ansorge, W., Bartek, J., and Draetta, G. (1993). Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J. Cell Biol. 121, 101-111.
23. Parsons, P.G., Hansen, C., Fairlie, D.P., West, M.L., Danoy, P.A., Sturm, R.A., Dunn, L.S., Pedley, J., and Ablett, E.M. (1997). Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells. Biochem. Pharmacol. 53, 1719-1724.
24. Qiu, L., Kelso, M.J., Hansen, C., West, M.L., Fairlie, D.P., and Parsons, P.G. (1999). Anti-tumor activity in vitro and in vivo of selective differentiating agents containing hydroxamate. Br. J. Cancer 80, 1252-1258.
25. Rhind, N., Furnari, B., and Russell, P. (1997). Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev. 11, 504-511.
26. Richon, V.M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R.A., and Marks, P.A. (1998). A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl. Acad. Sci. USA 95, 3003-3007.
27. Richon, V.M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R.A., and Marks, P.A. (1996). Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc. Natl. Acad. Sci. USA 93, 5705-5708.
28. Rosenblatt, J., Gu, Y., and Morgan, D.O. (1992). Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA 89, 2824-2828.
29. Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T., and Nakanishi, O. (1999). A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA 96, 4592-4597.
30. Saunders, N., Dicker, A., Popa, C., Jones, S., and Dahler, A. (1999). Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res. 59, 399-404.
31. Schaar, B.T., Chan, G.K., Maddox, P., Salmon, E.D., and Yen, T.J. (1997). CENP-E function at kinetochores is essential for chromosome alignment. J. Cell Biol. 139, 1373-1382.
32. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
33. Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
34. Sorger, P.K., Dobles, M., Toumebize, R., and Hyman, A.A. (1997). Coupling cell division and cell death to microtubule dynamics. Curr. Opin. Cell Biol. 9, 807-814.
35. Sowa, Y., Orita, T., Minamikawa, S., Nakano, K., Mizuno, T., Nomura, H., and Sakai, T. (1997). Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 241, 142-150.
36. Taylor, S.S., and McKeon, F. (1997). Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89, 727-735.
37. Tsuchiya, E., Hosotani, T., and Miyakawa, T. (1998). A mutation in NPS1/STH1, an essential gene encoding a component of a novel chromatin-remodeling complex RSC, alters the chromatin structure of Saccharomyces cerevisiae centromeres. Nucleic Acids Res. 26, 3286-3292.
38. Wang, J.Y. (1998). Cellular responses to DNA damage. Curr. Opin. Cell Biol. 10, 240-247.
39. Waters, J.C., Chen, R.H., Murray, A.W., and Salmon, E.D. (1998). Localization of Mad2 to kinetochores depends on microtubule attachment, not tension. J. Cell Biol. 141, 1181-1191.